Jun Kato

9PUBLICATIONS
33CO-AUTHORS
Predictive and prognostic markersPhysical oceanographyCancer therapy (excl. chemotherapy and radiation therapy)Molecular medicineHost-parasite interactions
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jan 28, 2026
Prognostic Impact of Unplanned Hospitalization During First-Line Gemcitabine Plus Nab-Paclitaxel Therapy for Unresectable Pancreatic Cancer: A Single-Center Retrospective Observational Study.

Kazuki Watabe, Motoyasu Kan, Izumi Ohno

|Jul 12, 2024
Clinical outcomes and reintervention after endoscopic retrograde cholangiopancreatography in primary sclerosing cholangitis in absence of cholangitis.

Ryosuke Horio, Jun Kato, Takashi Taida

|Feb 13, 2024
Severe ulcerative colitis induced by COVID-19 vaccination.

Takashi Taida, Jun Kato, Kentaro Ishikawa

|Dec 28, 2020
Risk Factors for Acute Cholangitis Caused by Enterococcus faecalis and Enterococcus faecium.

Yuki Karasawa, Jun Kato, Satoshi Kawamura

|Jun 12, 2020
Multicenter survey on mesalamine intolerance in patients with ulcerative colitis.

Sakiko Hiraoka, Akiko Fujiwara, Tatsuya Toyokawa

|Jun 08, 2017
Appendectomy as a Risk Factor for Bacteremic Biliary Tract Infection Caused by Antibiotic-Resistant Pathogens.

Koki Kawanishi, Jun Kinoshita, Hiroko Abe

Pageof 2

Frequent Collaborators

3 joint publications

Hideyuki Tamai

1 joint publications

Yasunobu Yamashita

1 joint publications

Koki Kawanishi

1 joint publications

Sakiko Hiraoka